Clinical Trial Update: Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant epirubicin, cisplatin, and capecitabine (ECX) followed by definitive chemoradiation with or without surgery for squamous ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• ELLENCE (Epirubicin hydrochloride)
• Platinol (cisplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Oesophageal Carcinoma | Phase 2 | Status: COMPLETED